Augmented Reality-based Telerehabilitation Platform for Patients With Stroke
NCT ID: NCT06963645
Last Updated: 2025-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-06-30
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reaching in Stroke
NCT02654951
Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation
NCT05903235
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
NCT03559829
Wrist-worn Sensors for Tele-Rehabilitation of the Hemiparetic Upper Extremity
NCT03431025
Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation
NCT05467813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation Group
Participants will use a mobile medical device in a augmented reality (AR) headset for 30 minutes daily to support their rehabilitation process after stroke by completing assessments and training programs.
AR rehabilitation app
The intervention will consist of an 8-week home rehabilitation program during which the participant will have 1) a total of 7 weekly remote video visits with a therapist and 2) daily at-home exercises using the AR headset with rehabilitation app, done independently.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AR rehabilitation app
The intervention will consist of an 8-week home rehabilitation program during which the participant will have 1) a total of 7 weekly remote video visits with a therapist and 2) daily at-home exercises using the AR headset with rehabilitation app, done independently.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ≥3 months post ischemic or hemorrhagic stroke
3. Upper extremity deficit with an FMA-UE score between 20-50
4. Able to operate the AR device independently or with the help of a caregiver
5. Sufficiently proficient in the English language to follow instructions from Reia
Exclusion Criteria
2. Vision or visual field impairment that interferes with the use of the AR headset
3. Severe photosensitivity that makes use of the AR headset uncomfortable
4. History of visually provoked seizures
5. Hearing aids
6. Cardiac pacemaker
7. Implantable cardioverter-defibrillator (ICD)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Berkeley
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maarten Lansberg
Professor of Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maarten Lansberg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
80062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.